TrialsgrambetaRCTs are beautiful

4S

1994

Scandinavian Simvastatin Survival Study

In 4,444 patients with CAD and total cholesterol 5.5–8.0 mmol/L, simvastatin reduced all-cause mortality compared with placebo.

Result

Efficacy: All-cause mortalityRR 0.7

Below 1 favours simvastatin, above 1 favours placebo.

Event rates
Absolute difference
3.3 points

The absolute difference is derived from the event rates.

Also reported: Major coronary events down 34 %.

Original publication
Subtopic
Statins
Design
Double-blind RCT, median 5.4 yr
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
Scandinavian Simvastatin Survival Study Group. Lancet. 1994;344(8934):1383-1389.doi 10.1016/S0140-6736(94)90566-5

Discussion & critique

First trial to show statin mortality reduction: ended the cholesterol-controversy era. Population enriched for high baseline cholesterol; lower-LDL questions answered later.